Rapid immunochromatographic assay for qualitative detection of Influenza A and B antigens using nasopharyngeal swabs. Enables differential identification of influenza strains including H1N1 subtype in symptomatic patients with results available within minutes.
Manufactured by
Formello (RM), Italy
Futura System Group S.r.l. is an Italian company located in the suburbs of Rome that manufactures and distributes latest generation and high-quality in vitro diagnostics (I.V.D.) for Clinical Chemistry, Coagulation, Immunoturbidimetry , Serology and other products for the Analysis Laboratories. Since 1984 the Company has operated in the diagnostic market for Clinical Laboratories, and has always aimed at the people s health. Its mission is developing innovative in-vitro diagnostic products with high stability and sensitivity, providing the analytical laboratories with results ever more accurate in order to better service the patients. Products Futura Systems Group has developed a catalogue of reagents and instruments to satisfy the needs of the Analysis Laboratories. All Clinical Chemistry and Immunoturbidimetry Reagents are liquid, stable and ready to use. The company provides ready-to-use diagnostic kits with own brand, or semi-manufactured products as bulk reagents or O.E.M. (unlabeled vials). Futura System Group s.r.l. is ready to help its distributors by supplying contractual and administrative documentation, in order to obtain the registration in every country across the world. Research To Future Systems Group, research is the key to identify and develop new reagents and products for the IVD market. The team of chemists and biologists is constantly working on improving the products which have been developed already as well as developing new IVD with performances that better meet the latest needs of the market. Production Futura System Group S.r.l production department uses advanced instruments and equipment. Chemists and biologists who take care of the Quality Control use the best practices and monitor the complete manufacturing cycle so that the high quality and efficiency of diagnostics is guaranteed with low costs. This leads to a faster and effective answer to the customers needs. Marketing Futura System Group s.r.l. directly deals with labs analysis with its sales force in the Italian market. In addition, the Company works worldwide with specialized dealers. The Company is market-oriented and aims at supplying quality, services and convenience, considering the importance of customers satisfaction. The after-sales policy offers a telephone hotline and training sessions for the specialized dealers. All the technical staff is highly qualified and knowledgeable in dealing with the issues that its customers laboratories may present. Futura System Group s.r.l. has a significant market share and sells its products in many countries, applying carefully and punctually its marketing policy which is based on the latest technologies as well as on the customers needs. As an exhibitor, the Company attends some of the most important international medical fairs, for example Medica in Dusseldorf, Arab Health in Dubai, LabIndonesia in Jakarta. Quality The company is EN ISO 9001 and EN ISO 13485 certified. The reagents are CE certified and manufactured according to the IVD law 98/79/CE and the 1271/2008 (CLP) Directive. The high quality of diagnostics is verified and granted by the application of an internal Quality Control Protocol, which monitors the whole manufacturing cycle, from raw materials to finished kits. Every step related to the processing and the storage is verified and validated in order to provide the clients with high-performing products and constant quality. The Internal Quality Controls department issues a report for every lot. Samples of each lot are stored until its expiration date, in case further control is requested. There is a partnership with one of the most important university in Rome, which cooperates in the research phase and also deals with Quality Tests. Social Responsibility Futura System Group safeguards people s health. The company is actively involved in helping non-profit companies that are health care providers in the developing countries. Furthermore, the Company holds training sessions addressed to the staff who work in the analytical laboratories in order to improve their knowledge.This will result in a further improvement of the developing countries. The Ethic Code Through the application of its Ethic Code, Futura System Group always pursues high standards of ethics and code of conduct. The company is committed to the application of high-profile behavioural norms in order to make every day worth. The company aims at being recognized as a virtuous one with a long tradition in the research as it has always been engaged in providing people worldwide with a better quality of life.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Anbio Biotechnology Limited
Germany · 1 relevant product
AccuBioTech Co., Ltd.
China · 1 relevant product
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
Hangzhou Frenovo Biotech Co., Ltd
China · 1 relevant product
Bio-Novum Sp.z o.o.
Poland · 1 relevant product
Guangzhou Labsim Medical Diagnostics Co., Ltd.
China · 1 relevant product
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 3 relevant products
VEDALAB SAS
France · 2 relevant products
Zhejiang Orient Gene Biotech Co.,Ltd.
China · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
63 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 115 closest product alternatives
Anbio Biotechnology Limited · Germany
Rapid immunochromatographic assay for simultaneous detection of influenza A and B viral antigens. Provides point-of-care results for acute respiratory illness diagnosis.
AccuBioTech Co., Ltd. · China
Rapid immunoassay for simultaneous detection of influenza A and B viruses. Enables quick differentiation of influenza strains in acute respiratory illness cases.
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD · China
Rapid diagnostic test for simultaneous detection of influenza A and B viruses using nasopharyngeal or throat swab specimens. Provides reliable results for clinical decision-making in respiratory illness assessment.
Hangzhou Frenovo Biotech Co., Ltd · China
Rapid immunoassay for simultaneous detection of influenza A and B antigens. Provides quick diagnosis of seasonal influenza infection.
Bio-Novum Sp.z o.o. · Poland
Rapid immunochromatographic test for simultaneous detection of Influenza A and B antigens in respiratory samples. Delivers results within 10-15 minutes, enabling quick clinical decision-making in point-of-care and laboratory settings. Intended for use during suspected influenza infection to guide treatment and infection control protocols.
Guangzhou Labsim Medical Diagnostics Co., Ltd. · China
Rapid immunochromatographic test kit for simultaneous detection of Influenza A and B virus antigens in respiratory specimens. Delivers results within 10-15 minutes, enabling quick clinical decision-making in point-of-care settings. Suitable for emergency departments, urgent care clinics, and routine screening during flu seasons.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
An immunochromatography-based diagnostic kit for simultaneous detection of both Influenza A and B antigens. Results are available in as little as 15 minutes with high sensitivity and specificity. The kit features an easy-to-use, user-friendly format suitable for clinical testing.
VEDALAB SAS · France
Immunochromatographic rapid test for qualitative detection of influenza A and B viruses in nasal swab samples. Facilitates rapid diagnosis during influenza surveillance and clinical assessment.
Zhejiang Orient Gene Biotech Co.,Ltd. · China
Point-of-care diagnostic test for simultaneous detection of influenza A and B viruses. Results available within 10-15 minutes, enabling rapid clinical decision-making.
guangzhou biotron technolongy co.,ltd · China
Rapid diagnostic test for detection and differentiation of influenza A and B viruses from respiratory samples for acute respiratory infection diagnosis.
Operon S.A. · Spain
A rapid diagnostic test for the simultaneous detection of Influenza A and B viruses in human samples. Used for in vitro diagnosis of respiratory infections.
Anhui Deepblue Medical Technology Co., Ltd. · China
Rapid multiplexed test for simultaneous detection of influenza A and B viruses. Enables quick differentiation of influenza strains for appropriate clinical management.
103 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products